Bishwajit Das

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bevacizumab and trastuzumab are two antibody based antiangiogenic drugs that are in clinical practice for the treatment of different cancers. Presently applications of these drugs are based on the empirical choice of clinical experts that follow towards population based clinical trials and, hence, their molecular efficacies in terms of quantitative(More)
  • 1